Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers

被引:35
作者
Davies, NM [1 ]
Jamali, F [1 ]
机构
[1] UNIV ALBERTA,FAC PHARM & PHARMACEUT SCI,EDMONTON,AB T6G 2N8,CANADA
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1997年 / 16卷 / 07期
关键词
intestinal permeability; Cr-51-EDTA; non-steroidal antiinflammatory drug small intestine; metronidazole; nitric oxide;
D O I
10.1177/096032719701600701
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Recently, NSAID-induced changes in both the structure and function of the distal intestine have been found to occur more frequently and with greater toxicological significance than previously thought. We have previously validated a suitable animal model to evaluate intestinal permeability changes using orally administered Cr-51-EDTA that correlates with intestinal ulceration. In this study we investigated the suitability of metronidazole and the nitroxide stable free radical scavenger (tempo) as protective agents against NSAID-induced intestinal permeability. Male Sprague-Dawley rats were dosed with two doses of metronidazole (50 mg/kg, 12 and 1 h pre-NSAID) or a single 100 mg/kg dose of tempo 1 h prior to NSAIDs. The urinary excretion of the orally administered marker Cr-51-EDTA was measured. Both tempo and metronidazole dramatically reduced indomethacin (20 mg/kg) and flurbiprofen (10 mg/kg)-induced intestinal permeability. All the animals exposed to indomethacin alone died within 48-96 h and presented with histological evidence of drug-induced enteropathy, ulceration and frank peritonitis. Protection by tempo and metronidazole suggests that free radicals and/or bacteria may be important mediators in the pathogenesis of intestinal mucosal damage induced by NSAIDs. Nitric oxide donor compounds used concomitantly with NSAIDs may protect gastrointestinal tract.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 35 条
[1]  
AANAKKEN L, 1989, SCAND J GASTROENTERO, V24, P351
[2]  
ABRAMSON SB, 1991, ARTHRITIS RHEUM, V32, P1
[3]  
AKAMATSU H, 1991, ARCH DERMATOL RES, V282, P449
[4]  
ALLISON MC, 1992, NEW ENGL J MED, V327, P751
[5]   METRONIDAZOLE REDUCES INTESTINAL INFLAMMATION AND BLOOD-LOSS IN NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED ENTEROPATHY [J].
BJARNASON, I ;
HAYLLAR, J ;
SMETHURST, P ;
PRICE, A ;
GUMPEL, MJ .
GUT, 1992, 33 (09) :1204-1208
[6]  
BJARNASON I, 1993, GASTROENTEROLOGY, V104, P832
[7]  
COLLINS AJ, 1995, BRIT J RHEUMATOL, V34, P727
[8]   EFFECTS OF METRONIDAZOLE AND MISOPROSTOL ON INDOMETHACIN-INDUCED CHANGES IN INTESTINAL PERMEABILITY [J].
DAVIES, GR ;
WILKIE, ME ;
RAMPTON, DS .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (03) :417-425
[9]   ANTIINFLAMMATORY DRUG-INDUCED SMALL-INTESTINAL PERMEABILITY - THE RAT IS A SUITABLE MODEL [J].
DAVIES, NM ;
WRIGHT, MR ;
JAMALI, F .
PHARMACEUTICAL RESEARCH, 1994, 11 (11) :1652-1656
[10]   TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN THE LARGE-INTESTINE [J].
DAVIES, NM .
DISEASES OF THE COLON & RECTUM, 1995, 38 (12) :1311-1321